Financials Medlive Technology Co., Ltd.

Equities

2192

KYG5961B1041

Advertising & Marketing

Delayed Hong Kong S.E. 09:58:02 2024-04-29 pm EDT 5-day change 1st Jan Change
8.15 HKD -0.12% Intraday chart for Medlive Technology Co., Ltd. +3.68% -3.77%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025
Capitalization 1 15,807 5,404 5,487 5,487 -
Enterprise Value (EV) 1 11,941 1,228 5,603 1,144 1,076
P/E ratio 347 x 47.3 x 23.4 x 26.6 x 28 x
Yield 0.08% 0.87% 1.43% 1.9% 2.15%
Capitalization / Revenue 55.6 x 17.2 x 13.6 x 10.6 x 8.61 x
EV / Revenue 42 x 3.91 x 13.6 x 2.21 x 1.69 x
EV / EBITDA 156 x 17.4 x 67.1 x 10.5 x 7.79 x
EV / FCF - - 15.1 x 14.6 x 8.84 x
FCF Yield - - 6.63% 6.83% 11.3%
Price to Book 3.57 x - 1.17 x 1.11 x 1.03 x
Nbr of stocks (in thousands) 713,226 717,348 726,962 726,962 -
Reference price 2 22.16 7.534 7.548 7.548 7.548
Announcement Date 3/24/22 3/23/23 3/25/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 1 - 284.4 314.1 412 516.8 637.3
EBITDA 1 - 76.61 70.39 83.45 109.3 138
EBIT 1 - 73.07 61.4 74.08 93.41 123.8
Operating Margin - 25.69% 19.55% 17.98% 18.08% 19.43%
Earnings before Tax (EBT) 1 - 69.93 135 253.1 276.8 241.2
Net income 1 85.2 40.62 117.3 242.3 240.4 210.9
Net margin - 14.28% 37.36% 58.81% 46.52% 33.1%
EPS 2 0.1592 0.0639 0.1593 0.3299 0.2838 0.2694
Free Cash Flow 1 - - - 72.82 78.12 121.7
FCF margin - - - 17.72% 15.12% 19.1%
FCF Conversion (EBITDA) - - - 92.24% 71.45% 88.17%
FCF Conversion (Net income) - - - 30.99% 32.5% 57.7%
Dividend per Share 2 - 0.0170 0.0654 0.1081 0.1434 0.1624
Announcement Date 6/29/21 3/24/22 3/23/23 3/25/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 130.7 153.8 132 182.1 173.5 - 209.3 273.3
EBITDA 1 - - - - - - 66.52 67.79
EBIT 1 34.93 38.14 24.14 37.26 31.8 - 45.22 49.7
Operating Margin 26.73% 24.8% 18.29% 20.46% 18.33% - 21.61% 18.18%
Earnings before Tax (EBT) 1 - - - - - - 136.4 140.3
Net income 1 - - 26.97 - - - 113.7 117.1
Net margin - - 20.44% - - - 54.35% 42.83%
EPS 2 - 0.0281 0.0365 0.1228 0.1339 0.1960 0.1500 0.1600
Dividend per Share - - - - - - - -
Announcement Date 8/26/21 3/24/22 8/25/22 3/23/23 9/21/23 3/25/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - -
Net Cash position 1 - 3,866 4,176 4,389 4,343 4,411
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - - 72.8 78.1 122
ROE (net income / shareholders' equity) - 5.21% 2.81% 4.6% 4.5% 3.96%
ROA (Net income/ Total Assets) - 1.87% 2.69% 4.2% 4.8% 5.1%
Assets 1 - 2,172 4,359 5,595 5,008 4,136
Book Value Per Share 2 - 6.210 - 6.440 6.770 7.340
Cash Flow per Share 2 - 0.0700 - 0.0200 0.1000 0.1400
Capex 1 - 54.9 1.35 4.69 5.77 4.47
Capex / Sales - 19.3% 0.43% 1.14% 1.12% 0.7%
Announcement Date 6/29/21 3/24/22 3/23/23 3/25/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7.548 CNY
Average target price
9.314 CNY
Spread / Average Target
+23.40%
Consensus
  1. Stock Market
  2. Equities
  3. 2192 Stock
  4. Financials Medlive Technology Co., Ltd.